Breaking News
December 19, 2018 - Protein may slow progression of emphysema, study finds
December 19, 2018 - Studying atrial fibrillation — and exploring new frontiers in precision health
December 19, 2018 - A New Way To Get College Students Through A Psychiatric Crisis — And Back To School
December 19, 2018 - Optum, UnitedHealthcare take action to help people affected by North Carolina winter storms
December 18, 2018 - Weight change in middle-aged, elderly Chinese Singaporeans related to increased risk of death
December 18, 2018 - Immune cells sacrifice themselves to protect us from invading bacteria
December 18, 2018 - Watching brain cells fire, with a twist of gravitational waves
December 18, 2018 - 2018 in Review
December 18, 2018 - Getting the Most Out of the CLARITY Technique
December 18, 2018 - NVF shoes provide a viable option for track and road racing
December 18, 2018 - CRISPR may restore effectiveness of chemotherapies used to treat lung cancer
December 18, 2018 - New app accurately measures and charts progression of skin wounds
December 18, 2018 - Persistent Discrimination ID’d Among Physician Mothers
December 18, 2018 - Cellphone technology developed to detect HIV
December 18, 2018 - A Stanford doctor hits the field with the 49ers — as their airway management physician
December 18, 2018 - The Rise of Anxiety Baking
December 18, 2018 - Just one night of sleep deprivation increases the urge to eat
December 18, 2018 - Study reveals mechanism behind failed remyelination in MS
December 18, 2018 - New genetic testing method increases the precision of biomarker analysis
December 18, 2018 - Simple technique to effectively treat underdiagnosed cause of debilitating chest pain
December 18, 2018 - Barbershop-based medical intervention can successfully lower blood pressure, new data shows
December 18, 2018 - Food labels have caused changes in consumers’ intake and industry’s use of key additives
December 18, 2018 - Sickest children could benefit from split liver transplants
December 18, 2018 - Scientists create patient-specific model to identify most effective treatment for appendix cancer
December 18, 2018 - New therapy for childhood blindness shows ‘very promising’ results
December 18, 2018 - Researchers discover promising new compound against Buruli ulcer
December 18, 2018 - Study finds significant use of traditional, complementary and alternative medicines in Sub-Saharan Africa
December 18, 2018 - California Farm Implicated in Outbreak of E. coli Tied to Romaine Lettuce
December 18, 2018 - Mobile health has power to transform HIV/AIDS nursing
December 18, 2018 - Celiac Vaccine in Clinical Trials at Columbia
December 18, 2018 - Research into mental health first aid prompts practical guidance and resources for workplace
December 18, 2018 - Researcher conducts study to investigate peripheral blood markers of Alzheimer’s disease
December 18, 2018 - Researchers identify link between mucus in the small airways and pulmonary fibrosis
December 18, 2018 - EU Commission’s Health Policy Platform to host EKHA program on transplantation
December 18, 2018 - Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors
December 18, 2018 - Small changes to cafeteria design can get kids to eat healthier, new assessment tool finds
December 18, 2018 - From Machines to Cyclic Compounds
December 18, 2018 - New study reveals best assessment tools to establish delirium severity
December 18, 2018 - Rice University scientists develop synthetic protein switches to control electron flow
December 18, 2018 - Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy
December 18, 2018 - Researchers identify potential target for new breast cancer treatments
December 18, 2018 - National Biofilms Innovation Centre award grant to Neem Biotech for novel anti-biofilm drug development
December 18, 2018 - Artificial intelligence and the future of medicine
December 18, 2018 - Montana State doctoral student receives grant for her work to improve neuroscience tool
December 18, 2018 - Early postpartum initiation of opioids associated with persistent use
December 18, 2018 - Russian scientists identify molecular ‘switch’ that could be target for treatment of allergic asthma
December 18, 2018 - Surgeons make more mistakes in the operating room during stressful moments, shows study
December 18, 2018 - Immune cells explode themselves to inform about the danger of invading bacteria
December 18, 2018 - Malnutrition in children with Crohn’s disease linked with increased risk of surgical complications
December 18, 2018 - FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)
December 18, 2018 - The long and short of CDK12
December 18, 2018 - Hologic’s Cynosure division introduces TempSure Surgical RF technology in North America
December 18, 2018 - CMR Surgical partners with Nicholson Center to launch U.S.-based training program for Versius
December 18, 2018 - Findings reinforce guidelines for cautious use of antipsychotics in younger populations
December 18, 2018 - Study finds new strains of hepatitis C virus in sub-Saharan Africa
December 18, 2018 - New battery-free, implantable device aids weight loss
December 18, 2018 - Parental alcohol use disorder associated with offspring marital outcomes
December 18, 2018 - Novel Breast Imaging Technique Might Cut Unnecessary Biopsies
December 18, 2018 - What can a snowflake teach us about how cancer spreads in the body?
December 18, 2018 - Management of nausea and vomiting in pregnancy costs the NHS more than previously thought
December 18, 2018 - Green leafy vegetables may reduce risk of developing liver steatosis
December 18, 2018 - Veganism linked to nutrient deficiencies and malnutrition if not planned correctly
December 18, 2018 - Coming Soon: A Tiny Robot You Swallow to Help You Stay Healthy
December 18, 2018 - Modified malaria drug proven effective at inhibiting Ebola
December 18, 2018 - Study finds epigenetic differences in the brains of individuals with schizophrenia
December 18, 2018 - Fitness instructors’ motivational comments influence women’s body satisfaction
December 18, 2018 - Study focuses on modification of lipid nanoparticles for successful brain cell targeting
December 18, 2018 - New gut bacteria may be effective against obesity, metabolic and mental disorders
December 18, 2018 - New two-in-one powder aerosol to upgrade fight against deadly superbugs in lungs
December 18, 2018 - Biofilms feed with swirling flows
December 17, 2018 - Study identifies specific neurological changes related to traumatic brain injury
December 17, 2018 - New study confirms geographic bias in lung allocation for transplant
December 17, 2018 - Research focuses on optimization of solid lipid nanoparticle that encapsulates Vinorelbine bitartrate
December 17, 2018 - Carpal tunnel syndrome – Genetics Home Reference
December 17, 2018 - A novel insulin accelerant
December 17, 2018 - Tips for caring for patients with disabilities, from a mother and physician
December 17, 2018 - Menopause-related sexual, urinary problems tied to worse quality of life
December 17, 2018 - In-school nutrition programs among students limit increases in BMI, finds study
December 17, 2018 - Risk for Hospitalization for Heart Failure Greater With Diabetes
December 17, 2018 - Food assistance may help older adults adhere to diabetes meds
Gene Therapy Offers Hope for Inherited Retinal Disorder

Gene Therapy Offers Hope for Inherited Retinal Disorder

image_pdfDownload PDFimage_print

Action Points

  • Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
  • Patients with inherited retinal disease due to biallelic mutation in the RPE65 gene had sustained functional vision improvement when treated with voretigene neparvovec (Luxturna), according to a phase III study in 29 patients.
  • Note that RPE65 is an isomerohydrolase enzyme (expressed in the retinal pigment epithelium) that converts vitamin A from an inactive to an active form, and is responsible for rod and cone functioning.

NEW ORLEANS — Gene augmentation by voretigene neparvovec (Luxturna) improves functional vision in patients with biallelic mutation in the RPE65 gene, a mutation that results in inherited retinal disease, researchers reported here.

Twenty seven of 29 (93%) of patients with Leber congenital amaurosis (LCA) who were treated with the investigational gene therapy had their vision improved to the degree that they could navigate a maze in low to moderate light. They also demonstrated improvement in light sensitivity and peripheral vision, according to Stephen R. Russell, MD, of the University of Iowa in Iowa City, and colleagues.

The improvement was maintained to 3 years, according to updated data from a phase III study presented at the American Academy of Ophthalmology (AAO) meeting.

In October, an FDA advisory committee unanimously recommended approval of the gene treatment for patients with vision loss due to confirmed biallelic RPEmutation-associated retinal dystrophy. The FDA is expected to render a decision no later than January 2018.

“So far, we have followed patients for up to 4 years, and have not seen any significant drop-off,” Russell said at an AAO, press briefing. “We will be observing these patients up to 15 years by FDA protocol.”

RPE65 is an isomerohydrolase enzyme expressed in the retinal pigment epithelium; this enzyme converts vitamin A from an inactive to an active form. The expression of the RPE65 gene is responsible for rod and cone functioning. Autosomal-recessive mutations in the RPE65 gene result in difficulty in navigating unfamiliar environments, night blindness, loss of visual acuity, and a progressive loss of the visual field.

The effect of noretigene neparvovec was studied in a 1-year open-label, randomized, controlled study period, after which patients in the control group could cross over to active treatment. The treatment was delivered bilaterally, 6 to 18 days apart.

The 31 patients, ages 4 to 44 years at the time of treatment, were randomized in a 2:1 ratio to treatment (n=21) or control (n=10).

The primary endpoint was the change in bilateral performance in the multi-luminance mobility test (MLMT), an endpoint designed specifically for LCA, at 1 year. The MLMT measures functional performance through navigation of a mobility course in which participants follow arrows and avoid obstacles. The test was conducted at various light levels, ranging from 1 to 400 lux. The course navigation was captured on video and graded for accuracy and time.

At 1 year, per the mean change in the bilateral MLMT score differed by 1.6 in favor of the active treatment (95% CI 0.72-2.41, P=0.0013). Those who received gene therapy also showed a marked improvement compared with controls in full-field light sensitivity (FST) threshold testing averaged over both eyes (P=0.0004) and MLMT change score for the first injected eye (P=0.0005).

However, the change in visual acuity averaged over both eyes was not significantly different between intervention and control patients (P=0.17).

The mean bilateral MLMT score change at 3 years for 20 patients originally randomized to gene augmentation was 1.8. In nine patients who crossed over, the mean bilateral score change was 2.1 relative to injection baseline after year 1.

Similarly, the mean change from baseline in white light FST was 2.04 at year 3 in 19 participants who received noretigene neparvovec. This same score improved by 2.69 at year 2 in the nine patients who crossed over.

The change in mean visual acuity score was consistent through year 2 for the crossover population and through year 3 in the population originally randomized to noretigene neparvovec. “We have a very small population, so there’s a lot of variability,” Russell stated.

“There were no serious ocular surgery concerns,” he said. “The complications that we saw were largely related to the procedure of placing the subretinal gene therapy as opposed to agent-related reactions.”

Ten patients (17%) had cataracts and three (10%) had intraoperative retinal tears that were treated at the time of gene therapy. Three patients (10%) had retinal deposits.

Irene Maumenee, MD, of the Ocular Genetics Laboratory at the University of Illinois in Chicago, said the results represent the beginning of a treatment wave of genetic eye disease, with further improvements down the road. She cautioned that it may be premature to treat without a full understanding of the variation in disease that occurs with mutation in the same gene.

“Has there ever been any treatment where the dosage was right from the beginning?” she stated. “Probably not. So if this is the first wave of treatment that would be 100% correct, [that ] is … maybe presumptuous. There are so many problems to overcome from the beginning.” Maumenee was not involved in the study.

Russell disclosed a relevant relationship with Spark Therapeutics.

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles